^In 3-month clinical studies, AQUIPTA significantly reduced monthly migraine days.1
†In a clinical study, 87.7% of patients who received AQUIPTA 60 mg did not have a migraine on day 1 after first dose compared to 74.8% on placebo.2
AQUIPTA is a privately funded prescription medicine, available at a discounted price via Airport Oaks Pharmacy. Airport Oaks can courier AQUIPTA anywhere in New Zealand.
At Airport Oaks, the maximum price charged to the patient will be NZ$352.82 (inclusive of GST) for a 60 mg x 28 tablet pack (28 days supply). Courier charges may apply, as required (typically $5-12 for metro vs rural deliveries, as of Sept 2024, and subject to change based on NZ post pricing).
Outside of the Airport Oaks access program, AQUIPTA is also available for private purchase with a prescription from any other pharmacy. It is suggested that you check the price with the selected pharmacy as prices may vary.
The access program may be expanded to other pharmacies, subject to them being able to meet certain criteria and signing up to the relevant terms and conditions of the access program. If a pharmacy wants to enquire about the access program, they should contact AbbVie on 0800 900 030.
References: 1. AQUIPTA® (atogepant) Data Sheet. 2. Schwedt TJ, et al. Cephalalgia. 2022;42(1):3-11.
NZ-AQP-240019. TAPS BG4309. ABB2630. Date prepared September 2025.